IMUFLO Trademark

Trademark Overview

On Friday, November 14, 2003, a trademark application was filed for IMUFLO with the United States Patent and Trademark Office. The USPTO has given the IMUFLO trademark a serial number of 78328231. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 11, 2009. This trademark is owned by GENENTECH, INC.. The IMUFLO trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ONCOLOGICAL DISEASES AND DISORDERS, IMMUNE DISEASES AND DISORDERS, ANGIOGENESIS DISEASES AND DISORDERS, OCULAR DISEASES AND DISORDERS, AND INFLAMMATORY DISEASES AND DISORDERS
imuflo

General Information

Serial Number78328231
Word MarkIMUFLO
Filing DateFriday, November 14, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 11, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2004

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ONCOLOGICAL DISEASES AND DISORDERS, IMMUNE DISEASES AND DISORDERS, ANGIOGENESIS DISEASES AND DISORDERS, OCULAR DISEASES AND DISORDERS, AND INFLAMMATORY DISEASES AND DISORDERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 9, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990

Trademark Events

Event DateEvent Description
Monday, May 11, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 11, 2009ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 8, 2008EXTENSION 4 GRANTED
Wednesday, October 8, 2008EXTENSION 4 FILED
Wednesday, October 8, 2008TEAS EXTENSION RECEIVED
Tuesday, April 1, 2008EXTENSION 3 GRANTED
Tuesday, April 1, 2008EXTENSION 3 FILED
Tuesday, April 1, 2008TEAS EXTENSION RECEIVED
Thursday, September 27, 2007EXTENSION 2 GRANTED
Thursday, September 27, 2007EXTENSION 2 FILED
Thursday, September 27, 2007TEAS EXTENSION RECEIVED
Tuesday, April 3, 2007EXTENSION 1 GRANTED
Tuesday, April 3, 2007EXTENSION 1 FILED
Tuesday, April 3, 2007TEAS EXTENSION RECEIVED
Tuesday, October 10, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 9, 2006PAPER RECEIVED
Saturday, July 15, 2006OPPOSITION TERMINATED NO. 999999
Saturday, July 15, 2006OPPOSITION DISMISSED NO. 999999
Monday, March 27, 2006OPPOSITION INSTITUTED NO. 999999
Monday, March 27, 2006OPPOSITION PAPERS RECEIVED AT TTAB
Friday, March 24, 2006CASE ASSIGNED TO TTAB
Monday, May 23, 2005NOTICE OF ALLOWANCE CANCELLED
Wednesday, October 26, 2005TEAS EXTENSION RECEIVED
Tuesday, April 26, 2005TEAS EXTENSION RECEIVED
Friday, February 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 23, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 16, 2004ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 16, 2004TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 12, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 31, 2004PUBLISHED FOR OPPOSITION
Wednesday, August 11, 2004NOTICE OF PUBLICATION
Thursday, June 3, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 3, 2004ASSIGNED TO EXAMINER
Tuesday, December 9, 2003NEW APPLICATION ENTERED IN TRAM

Related Keywords

imuflo disorders diseases angiogenesis ocular inflammatory immune preparations oncological pharmaceutical treatment